日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MCM10, a novel YAP1/TEAD4 target, drives gastric cancer progression by bridging DNA replication to stemness acquisition

MCM10 是一种新型的 YAP1/TEAD4 靶点,它通过连接 DNA 复制和干细胞特性获得来驱动胃癌的进展。

Xie, Fuda; Leung, Hoi Wing; Lyu, Yang; Yu, Peiyao; Feng, Tiejun; Chen, Bonan; Wu, Jialin; Tham, Jenson; Fang, Canbin; Cheung, Alvin H K; Chow, Chit; Jiang, Jianhui; Hu, Jintao; Zhang, Fengbin; Zhu, Chaowei; Zhong, Keli; Sun, Meiheng; Zhang, Ge; Yu, Sifan; Xu, Dazhi; Wang, Shouyu; Huang, Bing; Zhuang, Kangmin; Luo, Xiaobei; Li, Aimin; Guo, Qing; Gao, Chanchan; Zhang, Bin; Ma, Yuan; Wu, William Kk; An, Liwei; Wong, Chi Chun; Yu, Jun; To, Ka Fai; Kang, Wei

Stress-Survival Pathway Profiling Reveals MCM10 as a Candidate Biomarker of Hispanic Colorectal Cancer Disparities

应激生存通路分析揭示MCM10是西班牙裔结直肠癌差异的候选生物标志物

Islam Khan, Md Zahirul; Basnet, Urbashi; Nair, Soumya; Kulkarni, Aditi; Rangel, Frances A; Torres, Angel; Basu, Anamika; Almeida, Igor C; Al-Hilal, Taslim; Roy, Sourav

AtMCM10 facilitates SDSA-mediated intermolecular homologous recombination repair via liquid-liquid phase separation in DNA damage response

AtMCM10通过液-液相分离促进SDSA介导的分子间同源重组修复,从而参与DNA损伤反应。

Zhao, Xinjie; Zhang, Tianren; Jin, Dan; Chen, Hui; Xia, Shiqi; Bai, Li; Hao, Xiaohua; Huang, Liqun; Tian, Lianfu; Guo, Yan; Zhao, Yusheng; Li, Dongping; Gong, Zhizhong

Targeting MCM10 disrupts cancer stemness and counteracts sorafenib resistance in hepatocellular carcinoma.

靶向 MCM10 可破坏癌症干细胞特性,并对抗肝细胞癌的索拉非尼耐药性。

Zhang Ziyun, Liang Lu, Li Yi, Fan Ye, Liu Yao, He Zhifei, Wu Xiumin, Cong Li, Jiang Yiqun, Wan Tao

The m6A reader IGF2BP3 promotes HCC progression by enhancing MCM10 stability

m6A 阅读蛋白 IGF2BP3 通过增强 MCM10 的稳定性来促进肝细胞癌的进展。

Zhao, Lianwu; Huang, Hongyan; Luo, Linfei; Huang, Zixiang; Wu, Zhengqiang; Wang, Fenfen; Wen, Zhili

A critical threshold of MCM10 is required to maintain genome stability during differentiation of induced pluripotent stem cells into natural killer cells

在诱导多能干细胞分化为自然杀伤细胞的过程中,MCM10 的表达水平需要达到一个临界阈值才能维持基因组的稳定性。

Megan M Schmit ,Ryan M Baxley ,Liangjun Wang ,Peter Hinderlie ,Marissa Kaufman ,Emily Simon ,Anjali Raju ,Jeffrey S Miller ,Anja-Katrin Bielinsky

RTEL1 and MCM10 overcome topological stress during vertebrate replication termination

RTEL1 和 MCM10 克服脊椎动物复制终止过程中的拓扑压力

Lillian V Campos, Sabrina X Van Ravenstein, Emma J Vontalge, Briana H Greer, Darren R Heintzman, Tamar Kavlashvili, W Hayes McDonald, Kristie Lindsey Rose, Brandt F Eichman, James M Dewar

MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer

MCM10 是一种潜在的泛癌诊断、免疫学和预后生物标志物

Chen, Dengwang; Zhong, Na; Guo, Zhanwen; Ji, Qinglu; Dong, Zixuan; Zheng, Jishan; Ma, Yunyan; Zhang, Jidong; He, Yuqi; Song, Tao

Identification of Selective ATP-Competitive CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function

鉴定用于癌症干预的选择性 ATP 竞争性 CMG 解旋酶抑制剂,以破坏 CMG 复制体功能

Shengyan Xiang, Xingju Luo, Darcy Welch, Damon R Reed, Mark G Alexandrow

MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer

MCM10是一种预后生物标志物,与卵巢癌的免疫检查点相关

Wu, Zhenzhen; Wang, Yueyuan; Li, Juan; Wang, Huiling; Tuo, Xunyuan; Zheng, Jing